Sungtop S 250mg/125mg Injection
Marketer
Neoliva Formulations
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Sungtop S 250mg/125mg Injection
Combiflox 250mg/125mg Injection is a dual-action antibiotic used to combat diverse bacterial infections. Its mechanism involves inhibiting microbial growth, thus controlling infection spread. Administration must be strictly under a doctor's guidance; missed doses should be avoided, and the prescribed treatment course completed regardless of symptom improvement. Premature cessation may compromise its effectiveness. Potential side effects include, but are not limited to, nausea, vomiting, diarrhea, and dyspepsia. Worsening side effects require immediate medical attention. Seek emergency care for allergic reactions such as rashes, itching, swelling, or respiratory distress. Inform your physician of all current medications before commencing treatment. Expectant or nursing mothers should consult their doctor prior to use. Alcohol consumption should be avoided due to potential increased drowsiness. While usually non-impairing to driving ability, avoid operating vehicles if drowsiness or dizziness occurs. Adequate rest, a nutritious diet, and ample hydration are crucial for optimal recovery. Your physician may order blood tests and other examinations to monitor the medication's impact.
Uses of Sungtop S 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Sungtop S 250mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Sungtop S 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Sungtop S 250mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Sungtop S 250mg/125mg Injection works:
Ceftriaxone and Sulbactam, combined as Sungtop S 250mg/125mg Injection, offer a targeted antibacterial approach. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering their ability to thrive. Sulbactam's role as a beta-lactamase inhibitor counters bacterial resistance mechanisms, thereby bolstering Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Alcohol consumption alongside Sungtop S 250mg/125mg Injection presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Sungtop S (250mg/125mg) is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nevertheless, data from human trials are scarce.
Breast feedingCAUTION
Administering Sungtop S 250mg/125mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Sungtop S 250mg/125mg Injection can lead to reduced awareness, visual disturbances, drowsiness, and dizziness. Driving should be avoided if any of these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Sungtop S 250mg/125mg Injection to individuals with impaired renal function. Physician consultation is advised.
LiverCAUTION
The 250mg/125mg Sungtop S Injection requires careful administration in individuals with severe hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Dosage alteration for this injection isn't suggested for those with mild or moderate liver dysfunction.
What if you forget to take Sungtop S 250mg/125mg Injection :
Omit a Sungtop S 250mg/125mg Injection dose? Seek medical advice immediately.
Facts to Know About Sungtop S 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently